China channel feed

No clear an­swers: Yes, re­cent ac­tions against Chi­nese Amer­i­can sci­en­tists do pose a threat — but maybe those of­fi­cial con­cerns about es­pi­onage are valid too

7 years ago
People

In a first, HKEX re­ceives IPO pitch from lo­cal biotech look­ing to make it big in crowd­ed an­ti­bod­ies field

7 years ago
Financing

Elias Zer­houni: Fear of ‘tar­get­ed dis­crim­i­na­tion’ against Chi­nese-Amer­i­can sci­en­tists threat­ens an ex­o­dus of tal­ent. What do you think?

7 years ago
People

Trade ten­sions are im­ped­ing the flow of Chi­nese mon­ey to US biotechs — but how much?

7 years ago
Financing

Swiss court keeps ex-GSK sci­en­tist's broth­er be­hind bars as US push­es to ex­tra­dite him on R&D theft charges

7 years ago

In­cyte flips Chi­na rights of Macro­Gen­ic­s' PD-1 to an am­bi­tious Zai Lab keen on leapfrog­ging pi­o­neers with com­bos

7 years ago
Deals

Tasly Bio­phar­ma pitch­es long-await­ed IPO — will it trig­ger an­oth­er $1B gold rush on HKEX?

7 years ago
Financing

Gen­fit goes to Chi­na with a deal worth up to $228M for NASH drug

7 years ago
Deals

As Bris­tol-My­ers/Cel­gene tie up loose ends, BeiGene pock­ets $150M from PD-1 breakup

7 years ago
Deals

Fol­low­ing CAR-T pi­o­neer­s' foot­steps, Tes­sa launch­es Chi­na JV in $120M deal

7 years ago
Financing
Cell/Gene Tx

Han­soh grabs $1B wind­fall in the lat­est Chi­na phar­ma IPO to hit the Hong Kong ex­change

7 years ago
Financing

For­eign threats to NIH re­search: Sen­ate Fi­nance Com­mit­tee digs in

7 years ago

Spread­ing its wings in Chi­na with glob­al am­bi­tion, EpimAb snags $74M Se­ries B for bis­pe­cif­ic work

7 years ago
Financing

Fast mov­ing Chi­nese reg­u­la­tors wave third home­grown PD-1 to mar­ket

7 years ago

Trade war, CFIUS in­ter­ven­tions force a shift in strat­e­gy at Fo­s­un — sig­nal­ing some big po­ten­tial prob­lems for US biotechs

7 years ago
Pharma

The com­ing glut? Can­cer cell ther­a­py tri­als are boom­ing as Chi­na ri­vals US on new projects

7 years ago
R&D

Ready to har­vest its PD-L1, Al­pham­ab re­loads with $60M to nur­ture the bis­pe­cif­ic patch

7 years ago
Financing

‘I was shocked’: Con­tro­ver­sy brews at Emory af­ter promi­nent Chi­nese neu­ro­sci­en­tists are oust­ed over dis­clo­sure is­sues

7 years ago

Top 5 Chi­nese play­ers: What does Ever­est's land­mark deal with Im­munomedics say about the flur­ry of in-li­cens­ing to Chi­na?

7 years ago

Nine list­ings and $3.8B lat­er, HKEX cel­e­brates one-year biotech an­niver­sary with $194M CRO IPO

7 years ago
Financing
Outsourcing

MD An­der­son tries to as­sure re­searchers in town hall meet­ing that Asian ‘eth­nic­i­ty’ is not the dri­ving force be­hind purge

7 years ago

Lil­ly to sell lega­cy an­tibi­otics, Ce­clor and Van­cocin, to Chi­na-based part­ner in $375M deal

7 years ago

Three Asian MD An­der­son sci­en­tists purged in wake of NIH-di­rect­ed in­ves­ti­ga­tions on da­ta vi­o­la­tions

7 years ago

Chi­nese phar­ma­ceu­ti­cal man­u­fac­tur­er in spot­light af­ter weld­ing ac­ci­dent kills 10

7 years ago
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times